Greg Jones buying into GBG might be helping.OPR is now quite dependant on GBG as it will be the major user. If only we could get rid on the CHM on the bottom of our shoe.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%